← Back to Clinical Trials
Recruiting NCT06098469

Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression

Trial Parameters

Condition Depression
Sponsor Centre Hospitalier Universitaire de Besancon
Study Type INTERVENTIONAL
Phase N/A
Enrollment 22
Sex ALL
Min Age 25 Years
Max Age 65 Years
Start Date 2024-10-10
Completion 2025-02
Interventions
Neurofeedback sessions

Brief Summary

The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.

Eligibility Criteria

Inclusion Criteria: * Subjects aged 25 to 65 included * Information and signed informed consent * Patients with a diagnosis of major depressive episode in remission * MADRS score between 14 and 22 * Patients with residual symptoms as assessed by MADRS items * No cognitive impairment. * Right-handed Exclusion Criteria: * Subjects with legal incapacity or limited legal capacity * Subjects unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator * Pregnant women * Subjects in the exclusion period of another study or is on the "national volunteer list". * Subjects with another psychiatric pathology (bipolar mood disorder, psychosis, obsessive-compulsive disorder, addictive pathology, schizophrenia) * Subjects under a protective measure such as guardianship or safeguard of justice.

Related Trials